Skip to main content
C

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,056 across all filing types
Latest filing 2025-12-04 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Avadel Pharmaceuticals plc
Major Shareholding Notification Classification · 1% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel rules. This form is used for 'Opening Position Disclosure/Dealing Disclosure' by persons with interests in relevant securities representing 1% or more of an offeror or offeree during a takeover. Since this document details specific shareholdings, derivative positions, and trading activity related to a takeover scenario, it falls under the category of regulatory filings for major shareholding and takeover-related disclosures. Given the specific nature of the Irish Takeover Panel disclosure, 'RNS' (Regulatory Filings) is the most appropriate classification as it serves as the standard regulatory announcement for such disclosures.
2025-12-04 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 1% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel Act, 1997. This form is used by persons with interests in relevant securities representing 1% or more to disclose their positions and dealings in relation to an offeror or offeree during a takeover period. As this is a regulatory disclosure regarding shareholdings and dealings in the context of a takeover, it falls under the 'Major Shareholding Notification' category, which covers notifications of significant share ownership levels and related disclosures.
2025-12-04 English
Form 8.3 - Avadel Pharmaceuticals plc
Major Shareholding Notification Classification · 1% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act. It details the opening position and dealings in the securities of Avadel Pharmaceuticals PLC by Citadel Group. This type of disclosure is specifically related to major shareholding notifications and dealings during a takeover or merger process. Since it is a regulatory disclosure of shareholdings and dealings, it falls under the 'Major Shareholding Notification' category.
2025-12-03 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 1% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the interests, short positions, and dealings in the relevant securities of an offeror/offeree (Mural Oncology PLC) by a major shareholder (Citadel Group). This type of disclosure is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant ownership levels and changes during a takeover scenario.
2025-12-03 English
Form 8.3 - Avadel Pharmaceuticals plc
Major Shareholding Notification Classification · 1% confidence The document is a 'Form 8.3' disclosure filed under the Irish Takeover Panel rules. This form is used to report interests and short positions in relevant securities by persons with 1% or more interest during a takeover or merger process. This falls under the category of 'Major Shareholding Notification' (MRQ) as it specifically details share ownership levels and changes in holdings related to a takeover offer.
2025-12-02 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 1% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the interests, short positions, and dealings in relevant securities of an offeror/offeree (Mural Oncology PLC) by a major shareholder (Citadel Group). This type of disclosure is specifically designed to notify the market of significant shareholding changes and derivative positions during a takeover period. Since it does not fit into the specific categories of 'Major Shareholding Notification' (which usually refers to TR-1 filings) or 'Director's Dealing', and is a formal regulatory disclosure, it is best classified under the 'Regulatory Filings' (RNS) category.
2025-12-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.